EGFR - DIMA Biotechnology

Over the past year, Cadherin-3 (CDH3, P-cadherin), traditionally regarded as a classical cell-cell adhesion molecule, [...]

14
Jan

In November 2025, business development (BD) activities in the biopharmaceutical industry slowed slightly compared with [...]

08
Dec

Using multiple recombinant protein fragments from the same target—such as extracellular domains, functional regions, and [...]

08
Dec

In biomedical research and new drug development, recombinant proteins from three major model species—monkey, mouse, [...]

30
Nov

Membrane proteins are molecules that are critically important for life, undertaking key functions such as [...]

16
Nov

In October 2025, the global biopharmaceutical sector remained highly active, with innovation-driven collaborations and mergers [...]

06
Nov

The 2025 World Lung Cancer Conference (WCLC) will be held by the International Association for [...]

18
Sep

CCR1 (C-C motif chemokine receptor 1) is a G protein-coupled receptor (GPCR) involved in inflammatory responses [...]

20
Jun

Acute myeloid leukemia (AML) is a complex and highly heterogeneous hematologic malignancy closely associated with [...]

20
May

Efforts to improve traditional ADCs have primarily focused on the three key components: the antibody, [...]

29
Apr

Will SIRPα antibody combinatorial therapy be the next research hotspot?

Blocking Antibody Screening Service

ECD Proteins

Auto Draft